Restricted accessResearch articleFirst published online 2013-05
Design of Poly(ethylene Glycol)-Functionalized Hydrophilic Carbon Clusters for Targeted Therapy of Cerebrovascular Dysfunction in Mild Traumatic Brain Injury
Traumatic brain injury (TBI) involves the elaboration of oxidative stress that causes cerebrovascular dysfunction, including impairment of autoregulation of cerebral blood flow. Currently, there is no clinically effective antioxidant treatment for these pathologies. Most currently available antioxidants act through mechanisms in which the antioxidant either transfers the radical or requires regeneration, both of which are impaired in the toxic post-TBI environment. We previously reported that single-walled carbon nanotubes (SWCNTs) and ultrashort SWCNTs possess antioxidant activity, and their characteristics suggest that radical annihilation is the major mechanism. We have now developed a biologically compatible class of carbon-based nanovectors, poly(ethylene glycol)-functionalized hydrophilic carbon clusters (PEG-HCCs) that can be further functionalized with antibodies, and hence show promise as targeted drug delivery platforms. Here we report that PEG-HCCs possess innate antioxidant activity and can be rapidly targeted via an antibody to the P-selectin antigen in a model of injured cultured brain endothelial cells. One immediate application of this therapy is to vascular dysfunction that accompanies TBI and worsens outcome in the face of systemic hypotension. These in vitro results support the need for further investigation in animal models.
Get full access to this article
View all access options for this article.
References
1.
DickinsonB.C., ChangC.J.2011. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat. Chem. Biol., 7:504–511.
2.
KontosH.A., WeiE.P.1986. Superoxide production in experimental brain injury. J. Neurosurg., 64:803–807.
3.
HallE.D., AndrusP.K., YonkersP.A.1993. Brain hydroxyl radical generation in acute experimental head injury. J. Neurochem., 60:588–594.
4.
WeiE.P., KontosH.A., DietrichW.D., PovlishockJ.T., EllisE.F.1981. Inhibition by free radical scavengers and by cyclooxygenase inhibitors of pial arteriolar abnormalities from concussive brain injury in cats. Circ. Res., 48:95–103.
5.
DeWittD.S, ProughD.S.2003. Traumatic cerebral vascular injury: the effects of concussive brain injury on the cerebral vasculature. J. Neurotrauma, 20:795–825.
6.
FabianR.H., DeWittD.S., KentT.A.1995. In vivo detection of superoxide anion production by the brain using a cytochrome c electrode. J. Cereb. Blood Flow Metab., 15:242–247.
7.
RobertsonC.S., CherianL., ShahM., GarciaR.G., NavarroJ.C., GrillR.J., HandC.C, TainT.S., HannayH.J.2012. Neuroproection with an erythropoietin mimetic peptide (pHBSP) in a model of mild traumatic brain injury complicated by hemorrhagic shock. J. Neurotrauma, 29:1156–1166.
8.
AnsariM.A., RobertsK.N., ScheffS.W.2008. A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI. J. Neurotrauma, 25:513–526.
9.
RiggJ.L., ElovicE.P., GreenwaldB.D.2005. A review of the effectiveness of antioxidant therapy to reduce neuronal damage in acute traumatic brain injury. J. Head Trauma Rehabil., 20:389–391.
10.
MarshallL.F., MaasA.I., MarshallS.B., BricoloA., FearnsideM., IannottiF., KlauberM.R., LagarriqueJ., LobatoR., PerssonL., PickardJ.D., PiekJ., ServadeiF., WellisG.N., MorrisG.F., MeansE.D., MuschB.A.1998. Multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J. Neurosurg., 89:519–525.
11.
MuizelaarJ.P., MarmarouA., YoungH.F., ChoiS.C., WolfA., SchneiderR.L., KontosH.A.1993. Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial. J. Neurosurg., 78:375–382.
12.
ShuaibA., LeesK.R., LydenP., GrottaJ., DavalosA., DavisS.M., DienerH., AshwoodT., WasiewskiW.W., EmeribeU.2007. NXY-059 for the treatment of acute ischemic stroke. N. Engl. J. Med., 357:562–571.
BerlinJ.M., PhamT.T., SanoD., MilasZ., MarcanoD., LeonardA.D., KosynkinD.V., PriceB.K., Lucente–ShultzR., MyersJ.N., TourJ.M.2010. Effective drug delivery, in vitro and in vivo, by carbon-based nanovectors non-covalently loaded with paclitaxel. ACS Nano., 4:4621–4636.
18.
BerlinJ.M., PhamT.T., SanoD., MohamedaliK.A., MarcanoD., MyersJ.N., TourJ.M.2011. Noncovalent functionalization of carbon nanovectors with antibody enables targeted drug delivery. ACS Nano., 5:6643–6650.
19.
DuncanR.2011. Polymer therapeutics as nanomedicines: new perspectives. Curr. Opin. Biotechnol., 22:492–501.
20.
KnopK., HoogenboomR., FischerD., SchubertU. S.2010. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. Engl., 49:6288–6308.
JokerstJ.V., LobovkinaT., ZareR.N., GambhirS.S.2011. Nanoparticle PEGylation for imaging and therapy. Nanomedicine, 6:715–728.
23.
KoobA.O., DuerstockB.S., BabbsC.F., SunY., BorgensR.B.2005. Intravenous polyethylene glycol inhibits the loss of cerebral cells after brain injury. J. Neurotrauma, 22:1092–1111.
24.
Liu–SnyderP., LoganM.P., ShiR., SmithD.T., BorgensR.B.2007. Neuroprotection from secondary injury by polyethylene glycol requires its internalization. J. Exp. Biol., 210:1455–1462.
25.
MalhotraR., ValuckaiteV., StaronM.L., TheccanatT., D'SouzaK., AlverdyJ.C., AkhterS.A.2011. High-molecular-weight polyethylene glycol protects cardiac myocytes from hypoxia and reoxygenation-induced cell death and preserves ventricular function. Am. J. Physiol. Heart Circ. Physiol., 300:H1733–H1742.
26.
IsraelssonC., BengtssonH., KylbergA., KullanderK., LewénA., HilleredL., EbendalT.2008. Distinct cellular patterns of upregulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury. J Neurotrauma, 25:959–974.
GillespieK.M., ChaeJ.M., AinsworthE.A.2007. Rapid measurement of total antioxidant capacity in plants. Nat. Protoc., 2:867–870.
30.
ZuluetaM.J., FrívolaA.2009. ORAC and TEAC assays comparison to measure the antioxidant capacity of food products. Food Chem., 114:310–316.
31.
PriorR.L., HoangH., GuL., WuX., BacchiocaM., HowardL., Hampsch–WoodillM., HuangD., OuB., JacobR.2003. Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORACFL) of plasma and other biological and food samples. J. Agric. Food Chem., 51:3273–3279.
32.
Lucas–AbellanC., Mercader–RossM.T., ZafrillaM.P., GabaldonJ.A., Nunez–DelicadoE.2011. Comparative study of different methods to measure antioxidant activity of resveratrol in the presence of cyclodextrins. Food Chem. Toxicol., 49:1255–1260.
33.
OuB., Hampsch–WoodillM., RonaldP.L.2001. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J. Agric. Food Chem., 49:4619–4626.
34.
RazE., JensenJ.H., GeY., BabbJ.S., MilesL., ReaumeJ., GrossmanR.I., IngleseM.2011. Brain iron quantification in mil traumatic brain injury: a magnetic field correlation study. AJNR Am. J. Neuroradiol., 32:1851–1856.
35.
PottsM. B., KohS., WhetstoneW.D., WalkerB.A., YoneyamaT., ClausC.P., ManvelyanH.M., Noble–HaeussleinL.J.2006. Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets. NeuroRx, 3:143–151.
36.
FreemanL.R., KellerJ.N.2012. Oxidative stress and cerebral endothelial cells: Regulation of the blood–brain-barrier and antioxidant based interventions. Biochim. Biophys. Acta, 1822:822–829.
37.
WeiY., GuoM.2007. Hydrogen peroxide triggered prochelator activation, subsequent metal chelation, and attenuation of the fenton reaction. Angew. Chem. Int. Ed. Engl., 46:4722–4725.
38.
KochaT., YamaguchiM., OhtakiH., FukudaT., AoyagiT.1997. Hydrogen peroxide-mediated degradation of protein: different oxidation modes of copper and iron- dependent hydroxyl radicals on the degradation of albumin. Biochim. Biophys. Acta, 1337:319–326.
39.
SchopferP., PlachyC., FrahryG.2001. Release of reactive oxygen intermediates (superoxide radicals, hydrogen peroxide, and hydroxyl radicals) and peroxidase in germinating radish seed controlled by light, gibberellin, and abscisic acid. Plant Physiol., 125:1591–1602.
40.
BakerM.S., GebickJ.M.1984. The effect of pH on the conversion of superoxide to hydroxyl free radicals. Arch. Biochem. Biophys., 234:258–264.
41.
NicholsonP., DeanR.T.1993. The action of nine chelators on iron-dependent radical damage. Free Radic. Res., 20:83–101.
42.
BuettnerG.R.1985. Ascorbate autoxidation in the presence of iron and copper chelates. Free Radic. Res. Commun., 1:349–353.
43.
BuettnerG.R.1988. In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metals. J. Biochem. Biophys. Methods, 16:27–40.
44.
BuettnerG.R., JurkiewiczB.A.1996. Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat. Res., 145:532–541.
45.
BernhardtP.V., CaldwellL.M., ChastonT.B., ChinP., RichardsonD.R.2003. Cytotoxic iron chelators: characterization of the structure, solution chemistry and redox activity of ligands and iron complexes of the di-2-pyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues. J. Biol. Inorg. Chem., 8:866–880.
46.
RichardsonDR., SharpeP.C., LovejoyD.B., SenaratneD., KalinowskiM.I., BernhardtP.V.2006. Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity. J. Med. Chem., 49:6510–6521.
47.
McEverR.P., BecksteadJ.H., MooreK.L., Marshall–CarlsonL., BaintonD.F.1989. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel–Palade bodies. J. Clin. Invest., 84:92–99.
48.
HanY.H., KimS.H., KimS.Z., ParkW.H.2008. Antimycin A as a mitochondrial electron transport inhibitor prevents the growth of human lung cancer A549 cells. Oncol. Rep., 20:689–693.
49.
ZhaoH., JosephJ., FalesH.M., SokoloskiE.A., LevineR.L., Vasquez–VivarJ., KalyanaramanB.2005. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc. Natl. Acad. Sci. U.S.A., 102:5727–5732.
KeremZ., BaoW., HammelK.E.1998. Rapid polyether cleveage via extracellular one- electron oxidation by a brown-rot basidiomycete. Proc. Natl. Acad. Sci. U.S.A., 95:10373–10377.
52.
BarzM., LuxenhoferR., ZentelR., VincentM.J.2011. Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure-property relationships to better defined therapeutics. Polym Chem., 2:1900–1918.
53.
HärtelG., Fdez–NavamuelB., HasenederR.2007. Degradation of polyethylene glycol by Fenton reaction: a comparative study. Water Sci. Technol., 55:83–87.
54.
GoldingE.M, RobertsonC.S., FitchJ.C., GoodmanJ.C., BryanR.M.Jr. 2003. Segmental vascular resistance after mild controlled cortical impact injury in the rat. J. Cereb. Blood Flow Metab., 23:210–218.
55.
KentT.A., BitnerB.R., BerlinJ.M., RobertsonC.R., MarcanoD.C., FabianR.H., PautlerR.G., TourJ.M.2011. Antioxidant carbon-based nanotubes: in vitro characterization and in vivo effects on cerebrovascular regulation following mild traumatic brain injury. XXVth International Symposium on Cerebral Blood Flow, Metabolism and Function: Madrid, Spain.
56.
WhalenM.J., CarlosT.M., DixonC.E., RobichaudP., ClarkR.S., MarionD.W., KochanekP.M.2000. Reduced brain edema after traumatic brain injury in mice deficient in p-selectin and intracellular adhesion molecule-1. J. Leukoc. Biol., 67:160–168.
57.
GradyM.S., CodyR.F.Jr., MarisD.O., McCallT.D., SeckinH., ShararH., WinnH.R.1999. P-selectin blockade following fluid-percussion injury: behavioral and immunochemical sequelae. J. Neurotrauma, 16:13–25.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
